Approaches to enhancing the retroviral transduction of human synoviocytes
This report concerns a clinical trial for rheumatoid arthritis (RA), approved by the US National Institutes of Health and the Food and Drug Administration. An amphotropic retrovirus (MFG-IRAP) was used ex vivo to transfer a cDNA encoding human interleukin-1 receptor antagonist (IL-1Ra) to synovium....
Main Authors: | , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2001
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34116/ |